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Abstract
Nutrition status in hospitalized patients with COPD on non-invasive ventilation
Sara Kvien Jensen, RD, LMNT CNSC
Advisor: Corrine Hanson, PhD, RD, LMNT
Background: Nutrition is an important aspect of critically ill hospitalized patient care but the lack
of consistent nutritional guidelines for sub-critically ill patients with Chronic Obstructive
Pulmonary Disease (COPD) requiring non-invasive positive pressure ventilation (NPPV) may be
putting vulnerable patients at risk. Hand grip strength measurements are an emerging metric for
nutritional status.
Objective: The objective of this study is to determine if hospitalized patients with COPD on
NPPV show a difference in handgrip strength as a marker of nutritional status than those
hospitalized patients with COPD not requiring NPPV.
Methods: This was a prospective observational study of 10 hospitalized patients not requiring
NPPV (Group 1) and 5 hospitalized patients requiring NPPV (Group 2). 3 measurements of
handgrip strength on the patient’s dominate hand were averaged every alternating day during
hospitalization. Mineral status and physiological parameters were also recorded concurrently
with handgrip strength collection.
Results: The two groups were similar overall. Group 2 had a longer length of stay, averaging 5.2
(±0.45) days, with group 1 averaging 3.2 (±0.63) days (p=0.001). Mineral status and physiological
parameters between the groups were similar. Group 1 had an average change in handgrip
strength of 1.59 (±1.82) kg with group 2 having an average change of -1.08 (±1.22) kg (p=0.016).
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Conclusion: Hospitalized patients with COPD on NPPV may be at risk for a decline in nutritional
status compared to those not requiring NPPV as shown by a significant difference in change in
handgrip strength.
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Chapter 1: Introduction
When patients are admitted to the hospital for medical treatment, their care, including
nutrition, is often guided by evidence based guidelines. This is true of patients admitted to the
intensive care unit (ICU) for mechanical ventilation; however, this may not always be the case
for patients just a step down from being critically ill. Patients on non-invasive, pressure
supported ventilation (BIPAP or CPAP) may not be considered critically ill, but are often still very
sick. Frequently used to prevent mechanical ventilation, non-invasive measures of ventilation
leave more open ended guidelines on how to treat patients. In the case of mechanical
ventilation, starting enteral nutrition early, within 24-48 hours of admission to a critical care
unit, is a well-accepted standard of practice1. When it comes to non-invasive ventilation, the
issue of how to provide appropriate nutrition care becomes a gray area. Specialized nutrition
care is an important aspect of critical care, but the lack of consistent nutritional guidelines in
sub-critically ill patients may be putting vulnerable patients at risk for developing or
exacerbating malnutrition. Before best practices can be established, the background on the area
of interest needs to be examined. Measuring handgrip strengths is an emerging metric to
quickly assess nutritional status.2, 3, 4 This study seeks to examine the nutritional status of
hospitalized patients with Chronic Obstructive Pulmonary Disease (COPD) who required noninvasive means of ventilation, including Bilevel Positive Airway Pressure (BIPAP) and Continuous
Positive Airway Pressure (CPAP), by utilizing handgrip strength measurements. It is hypothesized
that patients with COPD requiring non-invasive ventilation will show evidence of a greater
decline in handgrip strength as a proxy for nutrition status compared to those with COPD who
do not require non-invasive ventilation.
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Chapter 2: Literature review
Background
The need for assisted ventilation is often a main reason patients are admitted to ICU,
but assisted ventilation as we know it today, is a fairly recent development. A full history of
mechanical ventilation has been described elsewhere, 5 the highlights are as follows.
Until the 1960, much of the ventilation assistance was provided by negative-pressure
ventilation machines, such as the “iron lung.” Non-Invasive positive pressure machines
in the form of bag and mask, and later bellow and mask, machines were available.
Advances in technology, as well as ongoing complication of the “tank” style negative
pressure ventilations led to a transition to positive pressure ventilation in the 1960s.
Today, these non-invasive ventilation modalities commonly include Bilevel Positive
Airway Pressure (BiPAP) or Continuous Positive Airway Pressure (CPAP).
Invasive ventilation began to become available in the 1940-1950s. At first, these
machines were quite simple, with much of the monitoring done manually. Over time,
they have developed into the more sophisticated machines common in today’s ICU.
Much research has been conducted on the care of patient receiving invasive positive pressure
ventilation due to the critical nature of providing this type of care. These patients are
monitored closely, with practice guidelines to provide evidence based patient care.
COPD
Chronic Obstructive Pulmonary Disease is a common cause of respiratory distress. As
reported by the American Lung Association, COPD is the third leading cause of death in the
United States of America.6 This is especially important in the elderly population, as they are
more prone to exacerbations of COPD. In fact, approximately 65% of patients over age 65
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discharged from hospitals were admitted with COPD exacerbations.6 Providing excellent
evidence based care to these patients is important to provide better outcomes, including
reduced re-admission rates and cost of care.6
COPD is defined as the presence of airflow limitations and its severity is based on lung
function tests utilizing spirometry. The airflow limitation for a diagnosis of COPD is often defined
as a FEV1/FVC ratio of <0.70.7 FEV1 is the volume that has been exhaled at the end of the first
second of forced expiration and FVC, or Forced Vital Capacity, is the volume of air forcibly
exhaled from the point of maximal inspiration. COPD is often measured in severity by using the
Global Initiative for Chronic Obstructive Lung Disease or GOLD score.7 This score is calculated in
the presence of an FEV1/FVC ratio of <0.70 and is based on post-broncholdilator FEV1. Lung
function tests would be conducted after the administration of an inhaled bronchodilator
medication to reduce variability.7 For example, a GOLD score of 1 or Mild COPD would have a
FEV1 that is ≥80% of the predicted value. A GOLD score of 2 or Moderate COPD would have a
measurement of ≥50% but <80% predicted FEV1. A FEV1 ≥30% but <50% predicted FEV1 would
be classified as a GOLD score of 3 or Severe COPD. Lastly, a FEV1 <30% would be classified as
Very Severe or GOLD 4.7 Classification of the severity of COPD can help guide the care of the
affected patients.

Treatment for COPD exacerbation is aimed at providing adequate oxygenation,
especially to prevent tissue acidosis associated with poor oxygenation. This includes the use of
medication to promote bronchodilation, corticosteroids, antibiotics, as well as oxygen therapy.
There are various means by which oxygen can be provided to patients. This can range from
simply supplementing extra oxygen, to pressure supported oxygenation, either through a mask
of varying size (non-invasive positive pressure ventilation) to full mechanical ventilation. Due to
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the high morbidity and difficulty weaning from ventilation associated with mechanical
ventilation, NPPV has been supported to be an alternative treatment. A Cochrane review of
NPPV supports its use as a primary treatment for exacerbations of COPD.8 NPPV should be
started early to help promote positive outcomes, including preventing severe acidosis, reducing
mortality, reducing the need for intubation, and decreasing treatment failure.8 NPPV has been
supported as a way of treating respiratory failure with similar improvement in gas exchange as
conventional ventilation, but with fewer serious complications (66% serious complications in the
mechanical ventilation group versus 38% in the NPPV group). 9
Nutrition in COPD
Nutrition is an important factor for good health, and this is very much the case for
patients with COPD. Malnutrition has been shown to be very common in patients with COPD.10
However it is difficult to quantify the prevalence of malnutrition in COPD as it varies depending
on the population studied and method used to measure malnutrition. Hunter, Carey, and Larsh
found in 1981 that between 19-60% of patient with COPD may be considered malnourished.11
The reason for this high prevalence of malnutrition is unclear. Possible etiology for malnutrition
in COPD ranges from increased inflammation12 to increased work of breathing,13 to increased
catabolism from high doses of corticosteroids often used for treatment in COPD.14 Whatever the
cause of malnutrition in COPD, it is definitely an issue that needs to be addressed, especially
during acute exacerbations of COPD that result in hospitalization.
In fact, nutrition status is such an important factor in COPD, that weight loss is
considered a prognostic factor in COPD. Patients with COPD who have a lower body mass index
(BMI) have been shown to have a higher rate of mortality.15 Conversely, improving nutrition
status and promoting weight gain has been shown to reverse the negative effects of low body
weight in COPD.15 In fact, multiple studies have shown that nutrition intervention, mostly
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through oral nutrition supplements, can improve outcomes in COPD. Schols et al. (1998)
demonstrated that nutrition intervention through oral nutrition supplementation improved
survivability of COPD by promoting weight gain.15 Participants who gained >2kg in 8 weeks,
when compared to a control with no weight gain, showed on multivariate analysis to be an
independent predictor of survival over 48 months of follow up (p=0.01).15 Another study by
Saudny-Unterberger et al. (1997) showed that patients with acute exacerbation of COPD whose
diet was supplemented with an oral nutrition supplement demonstrated improved oral intake
by an additional 10kcals/kg/day and a trend toward improved general well-being score (+11.96
versus -10.25 for the control, p=0.066). However, even with oral supplementation, patients in
this study did not improve measures of muscle strength, and were shown, through nitrogen
balance studies, to be in negative nitrogen balance.14 In order to promote better patient care for
patients with chronic and acute COPD, the nutrition status of the patient needs to be taken into
consideration, and improved if necessary.
Nutritional requirements in COPD may be difficult to calculate. The “gold standard” of
indirect calorimetry is expensive and not always readily available all hospital settings. An energy
intake of 27-30kcals/kg, or about 140% basal energy expenditure with a protein intake of
1.2g/kg has been show to maintain energy balance in patients with an acute exacerbation of
COPD.16 However, energy and protein intakes above this level may be necessary to improve
nutritional status.14, 16 This is especially important considering the high prevalence of
malnutrition in COPD patients.
Clearly, nutrition is an important part of the care of patients in respiratory distress, but
there does not appear to be a consensus on how best to provide nutrition care to these
patients. Many studies done on the importance of nutrition support in COPD utilized only oral
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nutrition supplements.12, 14, 15Another study did note, “As part of standard care, patients with
consistently poor intake despite interventions with oral nutrition support were enterally or
parenterally fed on 25% of eligible intake days.” 17 No distinction was made between patients
who received enteral versus parenteral nutrition. Of note, the same study found patients who
were only fed orally were less likely to meet nutritional requirements than those who received
enteral or parental nutrition.17 However, in order for patients to obtain oral intake on NPPV,
they must be able to tolerate breaks off NPPV.
If a patient is unable to obtain or maintain adequate nutritional intake from an oral diet,
the next step is to consider nutrition support. This is especially true of patients that may be
unable to tolerate breaks off of NPPV to take oral intake. The axiom, “If the gut works, use it,” is
very appropriate to consider when determining if a patient should receive enteral or parenteral
nutrition support. Barring any other complications, many patients admitted with respiratory
distress have working guts. As mentioned previously, early enteral nutrition is part of standard
therapy for patients who are invasively ventilated. The American Society for Parenteral and
Enteral Nutrition’s (ASPEN) Critical Care feeding guidelines supports the use of early enteral
nutrition in critically ill patients. In fact, guideline A4 states, “Enteral nutrition should be started
early, within 24-48 hours of admission.” 1 The difficulty in applying these guidelines is how to
define critical illness. Early enteral nutrition is commonly a part of patient care for invasively
ventilated patients but not necessarily patients on non-invasive ventilation, who may still be
considered critically ill. A poster session by Digby, D'Arsigny, and Parker (2012) detailing their
observation of non-invasively ventilated critically ill patients in an Ontario Academic Centre
showed significant gaps in the care provided to 32 patients on NPPV.18 This included gaps in
nutrition care, including almost 22% of patient receiving no “enteral nutrition” when on NPPV
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for greater than 24 hours. Patients who did receive “enteral nutrition”, it was provided orally
(n=18), via feeding tube (n=4), or a combination of both (n=3).18
Physicians may be wary of oral or enteral feeding in NPPV. Many patients may be made
NPO (nil per os, i.e. nothing by mouth) due to the risk of aspiration. In a study on complications
of non-invasive ventilation, discomfort from the mask was the most common complication,
occurring in 30-50% of patient.19 Aspiration is a very serious complication of NPPV and is
reported to occur about 5% of the time.19 Factors thought to reduce the incidence of aspiration
include patient selection and gastric drainage, when appropriate. Of note, over-sedation can
increase risk of aspiration, and care needs to be taken to ensure patients maintain the ability to
protect their airways.19 Other strategies have been shown to reduce the incidence of aspiration,
including simply maintaining the head of the bed above 30 degrees.20 If the patient is being
provided with enteral nutrition, routine verification of tube placement, assessment of GI
intolerance such as abdominal distention and excessive residuals, and removing enteral feeding
tubes as soon as possible are other ways to reduce the risk of this complication.20 However
there is very little research specifically demonstrating the safety of enteral nutrition provision on
NPPV.
Another often cited reason for not providing enteral nutrition to patients on NPPV is
complications with the mask sealing. One study did note nasogastric tube insertion, along with
the pressure applied to the respiratory system, can lead to worse air leaks from the mask. In
this study, adaptors were used to facilitate the provision of enteral nutrition and improve
patient comfort.21 Another study done by Antonelli, et al. (1998), also briefly mentions the use
of a seal connector in the dome of non-invasive ventilation mask to reduce air leakage for
patients with nasogastric tubes.9 However, this study does not delineate if the nasogastric tube
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was used for enteral feeding or gastric decompression9. Of note, the clinical guidelines
provided by the Royal Children’s Hospital in Melbourne, Australia recommend the use of
nasogastric or nasojejunal feeding tube for children on non-invasive ventilation. These
guidelines do note the increased risk of abdominal distention and risk of pressure area
formation and leaks from the mask.22 Children’s nutritional needs vary from those of adults, but
this does serve as a reminder of the importance of adequate nutrition in NPPV and the ability to
provide enteral feeding to those on NPPV. More conclusive research on the safety and best
practices for provided enteral nutrition to patients on NPPV are needed.
Parenteral nutrition is another means of providing nutrition support to patients. Due to
the ease of administration, and perceived decreased risk of complications, cautious physicians
may feel more comfortable providing parenteral nutrition to patients on non-invasive
ventilation. As noted in APSEN’s critical care feeding guideline A3: “Enteral Nutrition is the
preferred route of feeding over Parenteral Nutrition for critical ill patients who require nutrition
support therapy.” 1 Therefore, unless a patient has another complication prohibiting using the
patient’s GI tract, enteral nutrition should at least be attempted before parenteral nutrition.
Overall, ICU patients have better outcomes, including lower infectious complications, when
early enteral nutrition is provided over parenteral nutrition.23 If a patient is unable to tolerate
enteral feeding, ASPEN’s Critical Care feeding guideline B1 supports waiting 7 days in the
previously well-nourished patient before initiating parenteral nutrition.1 However, guideline B2
supports starting parenteral nutrition sooner in critically ill patients with evidence of proteincalorie malnutrition .1 If used correctly, parenteral nutrition can be beneficial in providing
adequate nutrition, but care does need to be taken to ensure the proper use of this therapy.
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Hand grip strength dynamometry
Hand grip strength dynamometry is gaining popularity as a means of assessing
nutritional status. ASPEN included handgrip strength as one of the six criteria for malnutrition in
their consensus statement on Characteristic Recommendations for the Identification and
Documentation of Adult Malnutrition (undernutrition).24 The inclusion of hand grip strength
dynamometry as criteria for malnutrition only seeks to highlight its importance in assessing
nutritional status. Using handgrip strength as a measure of nutrition status has been increasing
in popularity in more recent years but has been considered for longer. Watters, Haffejee,
Angorn, and Duffy discussed nutritional assessment utilizing hand grip dynamometry in 1985.4
Nutritional status is a multifaceted condition and handgrip strength is often utilized as one of
many criteria when looking at nutritional status. In ASPEN’s consensus statements on
malnutrition, two of the six malnutrition criteria must be present to diagnosis malnutrition.24 As
more research emerges on this means of looking at nutritional status, there is data to support
hand grip strengths as an independent predictor of nutritional status and change in nutritional
status.2 Muscle function reacts early to nutrition deficiency which makes hand grip strength
dynamometer useful in detecting more subtle changes in nutritional status.3 Due to its ease of
execution and benefits in being utilized as a marker of nutritional status and outcome predictor,
hand grip strength is being increasingly being used as an outcome variable in nutritional
intervention studies.3 Additional outcomes handgrip strength is associated with include ICUacquired paresis (ICUAP) or extreme muscle weakness from critical illness and mortality.25
Utilizing handgrip strength measurements is a simple way to look at nutritional status,
functional status, and to predict outcomes in hospitalized patients.
Handgrip strengths can be compared to standard values or as a change from baseline.
The JAMAR® brand dynamometer is frequently utilized in research and is often considered the

10
gold standard.2,3,26 Baldwin, et al in 2013 showed handgrip dynamometry to have a standard of
error of 2.8kg with a minimal detectable difference with a 95% confidence of 7.8kg in the right
hand for critically ill patients26. In the left hand, these numbers were 4.5kg standard of error and
12.5 minimal detectable differences at 95% confidence. In contrast, they showed healthy adults
to have a standard of error of 2.0kg in the right hand, and 2.6kg in the left, with a minimal
detectable difference at 95% confidence of 5.7kg in the right hand and 7.1kg in the left.26
However, this is just one study’s findings. ASPEN’s malnutrition guidelines for hand grip strength
in severe malnutrition states is defined as measurably reduced compared to the manufacturer
guidelines.24 The JAMAR Hydraulic Hand Dynamometer brand defines measurably reduced as
more than two standard deviations from the mean of their established normal values based on
age, sex, and hand.27 While comparing a patient’s hand grip strength to the normal values can
help to diagnosis malnutrition and be useful when only one measurement is available,
measuring a change from baseline can show changes in nutritional status over time.
Clearly, nutrition is important for patients receiving NPPV for respiratory distress but
how these patients receive nutrition can vary greatly. Protocols to support feeding patients on
invasive ventilation are widely accepted for their ability to improve outcomes. A consensus on
feeding patients on non-invasive ventilation would likely have similar success. Until this can be
done, further research needs to be done on the safety and best practices for feeding patient’s
on non-invasive ventilation. This study seeks to support this by starting to look at the nutritional
status of hospitalized patients with COPD to determine if there is a difference in nutritional
status between those requiring NPPV and those that do not. With the emergence of hand grip
strength as an easy, reliable predictor of nutritional status, this will be utilized as the primary
outcome.
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Chapter 3: Methods and Procedures
Approval
Data for this study were collected at CHI Health Saint Elizabeth Hospital, a local,
community based hospital. Institution Review Board (IRB) approval was obtained from the
University of Nebraska Medical Center IRB and the Catholic Health Initiative (CHI) IRB.
Permission for this study was also granted by the research council at CHI Health Saint Elizabeth
Hospital. Following IRB and institutional approval, informed consent was obtained from the
patients.
Criteria
Inclusion criteria were any adult patients ages 19 and over, admitted with COPD
exacerbations. Patients with a history of recent major surgery, trauma, or burns were excluded.
Also, patients with conditions that may alter nutritional status were excluded, including
cirrhosis, uncontrolled diabetes (in ketosis or more than 2 blood sugars >400mg/dL), and chronic
renal failure on dialysis. Patients were also excluded if they had a contraindication that would
prevent peripheral muscle strength testing, including acute or preexisting neurological
condition, or cognitive impairment to follow commands. Additional exclusion criteria included
end of life cares and significant language barrier. Patients who were mechanically intubated on
admission were excluded from the study to help narrow the population of the study. However,
those patients that are admitted on NPPV but later require more aggressive respiratory support
with mechanical ventilation were included.
The participants in this study were classified into 2 groups. Group 1 includes all COPD
patients who did not require non-invasive ventilation. Group 2 includes all COPD patient
enrolled in the study who did require non-invasive ventilation.
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Data Collection
Demographic and anthropometric data was obtained from medical record review,
including age, self-reported race, sex, height, weight, any change in weight in past 6 months, any
change in weight during hospitalization, and BMI. The primary nutritional status endpoint
obtained was hand grip strength as measured by a JAMAR® Hydraulic Hand Dynamometer.
Following the manufacturer’s instructions, measurements of hand grip strength were taken.
Three measurements on the patient’s dominate hand were recorded. Primary measurements
were taken within 24-48 hours of enrolling into the study, with subsequent measurements
taken every alternative day, until the patient discharged. Hospital outcomes included length of
duration on non-invasive ventilation, and if the patient was mechanically ventilated. Hospital
stay and mortality were also collected. Nutrition intervention was also collected including days
patient was NPO while on NPPV, or if the patient received enteral or parenteral nutrition. It was
also noted if the patient was on steroids, and if they participated in physical therapy.
Additional data was collected on the same day as the handgrip strength measurements.
Routine lab values were also collected, as available. These included visceral protein stores of
total protein, serum albumin, and pre-albumin. Measurements of mineral status were collected
such as serum iron, sodium, and potassium. Physiological parameters including blood urea
nitrogen (BUN), creatinine, and fasting (or morning) blood sugar were also recorded.
Additionally, average respiratory rate was collected. Average percent of recorded meal intake
were also recorded.
Statistical Analysis
Initial goal for recruitment was 30 patients not requiring BiPAP or CPAP (Group 1) and
30 patients requiring BiPAP or CPAP (Group 2). Based on previous literature,26 this goal was
established to achieve 80% power to detect a difference of 2.07 kg between the null hypothesis
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that both group mean changes in grip strength are 2.00 kg and the alternative hypothesis that
the mean of group 2 (patients requiring BiPAP or CPAP) is 4.07 kg with known group standard
deviations of 2.76 for each group and with a significance level (alpha) of 0.05 using a two-sided
Mann-Whitney test assuming that the actual distribution is normal.
Normal values were based on the standard of the handgrip dynamometer, which have
been described elsewhere. These normal values vary based on age, sex, and hand.27 Due to this
variance, it is not useful to compare the mean handgrips strengths between groups, as each
group did have slight differences in age, sex, and dominate hand. Instead, the averages of the 3
measurements for each patient were compared against the standard values. Average
measurements were considered to be in the normal range if they fell within 2 standard
deviations of the mean for that group.
Statistical analysis was conducted utilizing Statistical Package for the Social Sciences
(SPSS) software. Descriptive summaries were presented using means, standard deviations,
ranges, frequencies, and percentages. Continuous variables, specifically the change in grip
strength over the hospital stay, were compared between the groups using a Mann-Whitney test.
Categorical data, such as demographic information, was compared between the groups using
Fisher’s Exact test. All comparisons were conducted at the 0.05 level of significance.

Chapter 5: Results
Actual recruitment proved to be more difficult than anticipated. Initial estimates based
on expert input anticipated enrolling 30 patients in each group within 3 months. However,
patients were enrolled in the study for a 6 month period. 10 participants were enrolled in Group
1 and 5 participants were enrolled in Group 2. Demographics of the groups are shown in Table
1. Unfortunately, anticipate enrollment was not achieved due to a number of factors including
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patient not meeting the inclusion criteria. Of the patients screened to be in the study, around 45
did not meet the inclusion criteria. Many of the patients on NPPV in the hospital screened for
and excluded from the study, required it due to exacerbations of Congestive Heart Failure (CHF)
and did not have a diagnosis of COPD. Pneumonia, without any COPD, was also very common in
the screened patients. Many of the patient’s screened that did have a diagnosis of COPD were
also unable to participate due to cognitive reasons. COPD primarily affects the elderly and
combined with oxygenation issues, confusion, inability to follow commands, or inability to sign
one’s own consent was common in the population. Of those screened, 20 patients met the
exclusion criteria. Additional reasons for exclusion included poorly controlled diabetes (blood
sugar >400 on more than 1 occasion or in diabetic ketoacidosis) and recent, major surgery. A
number of patients also declined to consent to be in the study; 9 of the 24 patients that met
both the inclusion criteria and exclusion criteria declined to participate. This resulted in 63% of
patients able to participate in the study actually consenting to participate in the study. COPD
and being on NPPV can be very tiring, which was an often cited reason for not wanting to
participate in this study. Due to being unable to meet our enrollment goals, this study is unable
to reach 80% power and thus will be considered a feasibility or pilot study for assessing
nutritional status of COPD in hospitalized patient. It may also be a useful feasibility study on
taking measurements of handgrip strength in the hospital as a means of determining nutritional
status.
There were no statistically significant differences in the demographic variables between
the two groups. Group 1 included slightly older participants, with an average of 71.9 (±10.2)
years in the control group and average of 68.6 (±11.1) years in the experimental group (Table 1).
The proportion of males and females were the same in the two groups, with slightly more male
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participants in both groups (Table 1). All of the participants listed their ethnicity as white nonHispanic in their admission screening. Only 1 participate from group 1 was left handed.

Table 1: Demographic data of COPD patients per group

Age
Mean (SD)
Gender
Male
Female
Ethnicity
White non-Hispanic
Dominate hand
Right
Left

Group 1
(N=10)

Group 2
(N=5)

p-value

71.9 (10.2)

68.6 (11.1)

6 (60%)
4 (40%)

3 (60%)
2 (40%)

P=1.00

10 (100%)

5 (100%)

P=1.00

9 (90%)
1 (10%)

5 (100%)
0

P=1.00

P=.624

Anthropometrics between the two groups were compared. Participants in group 2 were
more likely to be obese with an average BMI of 44.2kg/m2 (Table 2). The average BMI in group 1
was 25.7kg/m2 (Table 2). When compared, there was a significant difference in BMI between
the two groups (P=0.005) (Table 2). Out of the 10 participants in group 1, 3 reported significant
weight loss prior to admission as opposed to none of the 5 participants in group 2 reporting any
weight loss (Table 2). Of those that lost weight, the average amount lost with 4.33 (±1.37) kg
with a range of 3.4-5.9kg lost (Table 2).
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Table 2: Anthropometrics of COPD patients per group
Group 1
Group 2
Mean (SD)
Mean (SD)
Height (cm)
175.5 (9.0)
164.1 (12.3)
Weight (kg)
80.6 (29.4)
117.88 (18.4)
2
BMI (kg/cm )
25.7 (8.0)
44.2 (9.2)
Range
12.2-37.4
31.9-55.8
# of patients with
3 / 10 participants
0 / 5 Participants
weight loss.
If loss, amount lost?
4.33kg (1.37)
NA
Range
3.4-5.9kg

Significance

P=0.005
P=0.505

Additional data about the participants were collected. Steroids and having Physical
Therapy could potentially cause differences in handgrip strength, so it was noted what patients
utilized these therapies. Overall, there was no difference during the hospitalization in use of
steroids or Physical Therapy between the two groups (p=1.00 and p=0.23, respectively) (Table
3). Average days patients were kept NPO were also collected. Only one patient in group 1 and
one patient in group 2 were kept NPO for at least a day (Table 3). Overall, there was no
difference in average days NPO between the groups (p=0.68) (Table 3). Patients that required
mechanical ventilation after failed initial conservative therapies were to be tracked, but no
patient in either group required this (Table 3). A marked difference between the groups was
found in the average length of stay. Group 1 averaged 3.2 ±0.63 day and group 2 averaged 5.2
±0.45 days in the hospital (p=0.001) (Table 3). Mortality was also tracked between the two
groups, with no patients in either group succumbing to the disease process (Table 3). Used as a
measure of severity of COPD, a GOLD Score was attempted to be tracked, but was unavailable
on all the patients in the study.
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Table 3: Additional COPD patient factors per group
Group 1
Group 2
N=10
N=5
Steroids
9 (90%)
4 (80%)

p-value
1.00

Physical Therapy

6 (60%)

5 (100%)

P=0.23

Days NPO
Mean (SD)
Mechanical
Ventilation
LOS
Mean (SD)
Range
Mortality

0.2 (0.63)

0.2 (0.45)

P=0.68

0 (0%)

0 (0%)

P=1.00

3.2 (0.63)

5.2 (0.45)

P=0.001

2-4 days
0 (0%)

5-6 days
0 (0%)

P=1.00

Additional lab values were tracked at each time point that handgrip strengths were
measured. These lab values include total protein, albumin, pre-albumin, iron, sodium,
potassium, blood urea nitrogen (BUN), creatinine, and blood sugar. Data were not available for
every patient at each time point. As only 1 patient was available to complete three sets of
handgrip strength measurement, mineral status and physiologic data is only available on 1
patient in group 2 for the third measure. No patient had pre-albumin levels drawn at any time
point during the study. The only measurement with a difference between the 2 groups was Iron
during the 2nd data collection. Group 1 averaged 10.88mg and group 2 averaged 13.57mg (Table
4). All other lab values showed no difference between the two groups at any time point of data
collection. Meal intakes, averaged of three meals per day, between the groups showed no
difference (Table 4). Respirations per minute showed no difference between the two groups
(Table 4).
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Table 4: Biochemical, meal intakes, and physiological data of COPD patients per group at each
time point
Group 1 Group 2 P-Value Group 1
Group 2
P-Value Group 2
1st
1st
2nd
2nd
3rd
Measure Measure
Measure Measure
Measure
*
Total
6.8
6.5
P=0.394 .
5.6
.
.
protein
N=6
N=4
N=0
N=1
N=0
(g/dL)
Albumin
3.53
3.08
P=0.199 .
3.1
.
.
(g/dL)
N=6
N=4
N=0
N=1
N=0
Pre-Albumin .
.
.
.
.
.
.
(mg/dL)
N=0
N=0
N=0
N=0
N=0
Iron
12.00
12.24
P=0.902 10.88
13.57
P=0.039 13.8
(g/dL)
N=10
N=5
N=6
N=3
N=1
Sodium
138.6
142.6
P=0.109 140.4
144.5
P=0.182 143
(mEq/L)
N=10
N=5
N=7
N=4
N=1
Potassium
4.1
4.22
P=0.951 4.19
4.12
P=1.000 4.3
(mEq/L)
N=10
N=5
N=7
N=4
N=1
BUN
18.5
24
P=0.158 23.9
30.3
P=0.449 51
(mg/dL)
N=10
N=5
N=7
N=4
N=1
Creatinine
0.88
1.04
P=0.270 0.96
1.15
P=0.345 1.43
(mg/dL)
N=10
N=5
N=7
N=4
N=1
Blood
161
199
P=0.327 165
183
P=0.449 131
Sugars
N=10
N=5
N=7
N=4
N=1
(mg/dL)
Meal Intakes 76
66
P=0.280 76
74
P=0.751 100
(%)
N=9
N=5
N=9
N=4
N=1
Respirations 19.4
19.0
P=0.946 19.0
21.5
P=0.825 20
(breaths/
N=9
N=5
N=9
N=4
N=1
min)
*No 3rd measurement was available for group 1.
The change in handgrip strength was the primary measurement for this study. The first
measure of handgrip strength was taken within 48 hours of admission, after consent was
obtained. Subsequent measures were taken every two days after the initial measure. The
average change in handgrip strength for group 1 was 1.59 (±1.82)kg, while the average change
in handgrip strength of group 2 was -1.08 (±1.22)kg (Table 5). Patients with COPD who require
BIPAP (group 2) averaged a negative change in handgrip strength (Table 5). Simple statistical
analysis using the Mann-Whitney test to compare the change in handgrip strength did meet the
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criteria for significance with a p-value of 0.016 (Table 5). Due to the limited sample size,
attempts to control for confounding variables, such as the difference in length of hospital stay,
by utilizing multiple regression was unable to be completed.
Table 5: Average handgrip strength of COPD patients per group at each time point and overall
change
Group 1
Group 2
Significance
Mean (SD)
Mean (SD)
1st Average Handgrip
P=0.178
26.00 (9.09)
19.53 (9.05)
Strength (kg)
N=10
N=5
nd
2 Average Handgrip
26.41 (8.86)
19.92 (8.98)
P=0. 440
Strength (kg)
N=9
N=4
3rd Average Handgrip
25.67 (-)
Strength (kg)
N=0
N=1
Change in handgrip
1.59 (1.82)
-1.08 (1.22)
P=0.016
strength (kg)
N=9
N=4

Handgrip strengths for each time point were compared against normal values for
handgrip strength. As previous described, the normal range is defined as within 2 standard
deviations of the mean for the patient’s age, sex, and hand. Overall, most of the measurements
in this study did fall into the normal range (Table 6). Only 1 patient from group 2 fell outside of
the normal range during the second time point of testing (Table 6). Only 1 patient was able to
complete a third set of handgrip strength measurements, and the average did fall within the
normal range. There appears to be no difference between the groups in regard to having
handgrip strengths within the established normal range.
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Table 6: Statistical analysis of handgrip strength measurements compared to normal values
per group.
Group 1
Group 2
1st measurement
100%
100%
P=1.0
within 2 SD of normal
N=10
N=5
Mean
2nd measurement
100%
75%
P=0.31
within 2 SD of normal
N=9
N=4
Mean
3rd measurement
100%
within 2 SD of normal
N=1
mean

Chapter 6: Discussion
Demographics
The demographics of the patients in this study are similar to the average patient with
COPD in the region the study was conducted. Average age for both groups was over 65 years
old, as is expected in a disease that typically affects older adults (Table 1). Overall, our patients
tend to be over age 65, with slightly more males then females, which fits the usual
demographics of COPD.6 All participants identified as Non-Hispanic, Caucasian (Table 1). As the
data collection center location is in Lincoln, Nebraska, it is expected the demographics of
participants to be similar to that of the city. Based on the most recent demographic data,
Lincoln’s population is 81% non-Hispanic or Latino White.28 The rest of the population of Lincoln
is 10% Hispanic or Latino, 5% African-American, about 2% Asian, about 2% identifying as two or
more races, less than 2% American Indian or Alaskan native, and less than 1% as Native
Hawaiian or other Pacific Islander.28 Overall, the demographics of the patient population were
comparable to the expected population, and there was little difference between the groups.
Anthropometrics
One exception in this study to the expected population of COPD patients was the BMI of
the participants. Being underweight is very common in COPD10,11,15,23 while these participants on
average were overweight in group 1 with an average BMI of 25.7 (±8.0)kg/m2 and obese in
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group 2 with an average BMI of 44.2 (±9.2)kg/m2. The difference in weight may have been
related to the participants in group 1 losing more weight prior to admit (Table 2). Weight loss is
also very common in COPD10,11,15,23..
In contrast, average BMI found by Schols, et al. (1998) was 24.0kg/m2 in their
retrospective study.15 A similar study on hospitalized patients with COPD by Thorsdottir and
Gunnarsdottir (2002) reported BMI of the patient’s in the study (n=10) and while the average
was not published, it was calculated by this author to average 23.8kg/m2.16 In correlation with
this study, Reeves, et al. (2013) identified that hospitalized COPD patients with increasing BMI
was a risk factor associated with less probability of meeting estimated energy and protein
needs. Average BMI in the Reeves’ study was 31.6 (±12.0).17 This study supports the same
trend with group 2 having a higher average BMI and overall decreased in handgrip strength
suggesting a decline in nutritional status.
Loss of muscle mass is very common in COPD. Even patients of a normal weight or
overweight may have substantial depletion of muscle mass in COPD that is not readily
apparent.23In another study conducted on hospitalized patients with COPD, mid-upper arm
circumference was measured a test of lean body mass. Average mid-upper arm circumference
was 21.18 ±2.31cm in males and 21.03±2.57cm in females (normal=27.4-35.5cm), showing
significant decrease in all participants.10 With an average BMI of 19.38±3.1kg/m2 nearly all
subjects in the lean body mass findings had low BMIs.10
Additional participant data
Additional data about this patient population was collected. Overall, little difference was
noted between the two groups except for longer length of stay in group 2. Patients requiring
NPPV tend to be sicker than those who do not require NPPV, so it is logical that group 2 has a
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longer average length of stay in the hospital. Our data showed these patients had a longer
length of stay by about 2 days (Table 3). Reported length of stay in other studies of acute
hospitalized COPD patients is variable. One study gave a median length of stay as 24 days with a
range of 2-48 days.17 Another study gave a range of 5-17 days for the control group and 8-33
days for the treatment group; all patients were admitted to the hospital for COPD
exacerbations.14 The longer length of stay for group 2 participants is significant as this may lead
to greater healthcare cost.
Use of steroids and physical therapy may affect handgrip strengths, but no difference
was found between the 2 groups in these areas (Table 3). Days NPO can also affect nutritional
status by limiting nutritional intake, but no difference in NPO days was found between the
groups. In fact, patients in both groups have very few average days NPO with only an average of
0.2 days from both groups (Table 3). No participants in the study required escalation of care to
needing mechanical ventilation and there was also no mortality noted during the study (table 3).
As a measure of COPD severity, GOLD status was attempted to be tracked, but was
unavailable for every patient in the study. Conducting the lung function tests necessary to
determine this GOLD score was likely a limiting factor. To the best of the author’s knowledge,
this is consistent with the literature, as no reference to a GOLD score for measuring COPD
severity was noted in the literature on nutrition status in COPD. Studies did utilize spirometry
and other pulmonary functions tests as a measure of COPD exacerbation severity without
calculating a GOLD score.10, 14, 15 One study did however utilize an APACHE (acute physiology and
chronic health evaluation) score as a measure of disease severity.17
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Biochemical and Physiological Data
Data on the mineral status and physiological lab values were recorded, as available, for
each patient on the days handgrip strength was collected. Only 1 difference between the groups
was found in average Iron status (hemoglobin) during the second set of measurements. Of
note, the lower iron average was in group 1 (table 4). Some of the lower average may be due to
the lower number of data points available, so 1 low value may affect the overall average more.
Not every patient had a second iron level drawn after admit, as evidence by the lower number
of data points for both groups (N=6 for group 1 and N=3 for group 2). The study by Gupta, et al.
in 2010 had similar collection of physiological and biochemical data that showed most
biochemical data to be within normal range but physiological parameters on average were
elevated.10 Average respiratory rate was given as 23.77±2.87 breathes/minute for males and
23.33±2.33 breathes/minute for females with a normal value range of 14-18 breathes/minute.10
Average respiratory rate found in this study ranged from 19.0-21.5 breathes/minute, which is
also elevated compared to the normal values range
Oral intake showed no difference between groups. This is important as oral intake is one
of the six ASPEN malnutrition criteria24 and can play a large part of nutritional status. However,
this study only recorded meal intakes as documented in the medical record. This does not take
into account what the meal was, or if the intakes meet the patient’s estimated nutritional
needs. Previous studies have shown that hospitalized COPD patients have elevated nutritional
needs, and would need to increase nutritional intake to above 140% basal energy expenditure
and protein intake of 1.2 g/kg to promote improved nutritional status. 16 Further research
comparing the nutritional intake of hospitalized patient with COPD non-requiring NPPV to those
with COPD requiring NPPV may be beneficial.
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Handgrip Strength
Handgrip strength was the outcome of most interest in the study. Not every participant
was able to complete more than 1 handgrip strength. Only 1 participant in group 2 was able to
complete 3 handgrip strength measurements. While the limited sample size does not
adequately power the study to support a strong conclusion, the data does suggest that there is a
difference in change in handgrip strength between patients in the hospital with COPD requiring
NPPV, and those in the hospital with COPD but not requiring NPPV(p=0.016) (Table 5). The
negative change in handgrip strength in patients with COPD who required BIPAP (group 2)
suggests that their nutrition status may have declined over the course of their hospital
admission especially when contrasted against the control group who overall saw an increase in
handgrip strength.
While there does appear to be a difference in change in handgrip strength of the two
groups, the difference is small. Group 1 only showed an average change of 1.59kg while group 2
showed an average change of -1.08kg. Both of these values are within the standard of error for
handgrip strength found by Baldwin, et al. in 2013 for critically ill patients.26 The change is
handgrip strength of both groups is also lower than the minimal detectable difference of critical
ill patients from the same study.26
Both groups did have a relatively short length of stay, with group 1 averaging just over 3
days and group 2 only averaging just over 5 days (Table 3). It is possible that this time frame was
not long enough to demonstrate differences in nutritional status. The ASPEN malnutrition
criteria utilize a time frame of 5-7 days in the criteria for moderate or severe malnutrition in
acute illness.24 With the exception of one participant in group 2, the rest of the participants did
have average handgrips that were considered to be within the normal range (Table 6). ASPEN’s
criterion for severe malnutrition does include measurably reduced handgrip strengths, but that
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is not criteria for moderate malnutrition.18 While the patients in this study may not meet the
conditions for severe malnutrition, group 2 did show an average decrease in handgrip strength
(Table 5).
A study by Flood, et al. compared hand grip strength measurements as a means of
measuring nutritional status to Patient Generated Subjective Global Assessment as a measure of
nutritional assessment.2 Compared to this study, handgrip strength was measured after 2 weeks
and was found to predict 42% of variability in change in nutrition status over time. 2 Flood, et al.
suggested that handgrip strengths could predict changes in nutritional status earlier than
Patient Generated Subjective Global Assessment and found handgrip strengths to independently
predict nutritional status as well as change in nutritional status,2 supporting this study’s
conclusion that the change in handgrip strength between the two groups demonstrates a
difference in change in nutritional status.
The results of this study suggest that care should be taken not to let these patients’
nutritional status, and thus handgrip strength, decrease further so they do not become severely
malnourished. All in all, there does appear to be a difference between the control group that did
not require NIPPV and the experimental group that did require NIPPV.
Feasibility
With the limited sample size of this study, one of the goals of the study was to
determine the feasibility of utilizing hand grip strength as an outcome of nutritional status in
COPD and patients on BIPAP. This is especially important considering the limited research in the
literature specifically on hospitalized patient’s that require BIPAP. Overall, conducting the
handgrip strength measurements was relatively simple. All patients were able to complete the
handgrip dynamometry test once enrolled in the study. The data also appears able to capture
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the information needed. Specifically this included if handgrip strength changed overtime and
how measures of handgrip strength compared to normal values. The biggest obstacle
encountered by this study was in the recruitment phase. A common barrier in research, this will
likely still be a factor if additional studies of this type are conducted. However, there are
strategies that may be helpful in minimizing this concern. Having a larger pool of participants to
draw from, including utilizing a large hospital or having multiple centers may help to mitigate
recruitment issues.

Chapter 7: Conclusion
Patient’s admitted to the hospital with COPD requiring NPPV may need more aggressive
nutrition care than those who do not require NPPV. Handgrip strength is an emerging metric for
assessing nutrition status, and the patient’s in group 2 that did require NPPV demonstrated a
decline in handgrip strength compared to the control in group 1.This data supports the
hypothesis that patients with COPD requiring non-invasive ventilation show evidence of a
greater decline in handgrip strength as a proxy for nutrition status compared to those with
COPD who do not require non-invasive ventilation. This study is limited in its scope, especially in
regards to the limited sample size. More research is needed in this area to confirm these
findings, as well as determine best practice guidelines for patient’s admitted with COPD who
require NPPV but not mechanical ventilation.
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